Tumor profiling / Research & navigation

Valius Sciences

Deep tumor profiling across DNA, RNA and proteins, using existing fixed tissue.

Kevin WimerSources checked Oct 22, 2026Updated Oct 23, 2026

Sample: Formalin-fixed, paraffin-embedded (FFPE) biopsy tissue. Fresh or frozen tissue is not required.[1]
Typical work: Whole-exome DNA, whole-transcriptome RNA, single-cell RNA and protein testing by immunohistochemistry, tailored to the case.[1]
Timing: The company lists 4–6 weeks for initial results. Confirmatory work may take longer.[1]
Published starting price: $35,000 direct pay. The company says discounts may be available for financial need.[1]

Before spending the money

Send the team your existing reports through its requested secure channel. Ask what the proposed work adds.
Have pathology confirm the available sample, its quality and how much would be consumed.
Ask which findings could change a decision now, which are exploratory, and who will help interpret them.
Get the scope, total price, expected deliverables and timeline in writing.

This is molecular profiling. Valius says it does not currently test drugs on live tumor cells and does not prescribe treatment.

Contact Valius Visit website

Sources 1

Valius profiling and patient FAQValius Sciences · Checked Oct 22, 2026
Fixed-tissue requirements, typical analyses, published starting price, timing and service boundaries.

Scope and disclosure

For people comparing this service with their care team. Inclusion is not a recommendation or a finding that it is right for your cancer.

Service details are reported by the linked provider unless noted. Confirm current access, requirements and costs directly. A company profile does not establish clinical benefit.

No paid placement. I have no investment, advisory role, paid partnership or other financial relationship with the twelve companies in this initial directory.

The linked company describes an available service.

Before spending the money

Related guides & organizations